What one share of TuHURA BIOSCIENCES, INC./NV holds
We are a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies.
TuHURA BIOSCIENCES, INC./NV’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.54 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.53 |
| Cash and investments | $0.02 |
| Debt | $0.06 |
| Book value | $0.29 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | — | −$558.91 | — | — | — | −$51.88 |
| 2020 | — | −$43.77 | — | — | — | $1.15 |
| 2021 | — | −$80.17 | — | — | — | $16.16 |
| 2022 | — | −$25.80 | — | — | — | $9.00 |
| 2023 | — | −$9.27 | — | — | — | $0.43 |
| 2023 | $0.00 | −$2.47 | $0.01 | −$1.01 | — | −$0.13 |
| 2024 | $0.00 | −$1.21 | $0.00 | −$0.79 | — | $1.20 |
| 2025 | $0.00 | −$0.63 | $0.00 | −$0.58 | — | $0.35 |
Common questions about TuHURA BIOSCIENCES, INC./NV
How much does one share of TuHURA BIOSCIENCES, INC./NV earn?
Over the last 12 months, TuHURA BIOSCIENCES, INC./NV lost $0.54 for each share.
Does TuHURA BIOSCIENCES, INC./NV pay a dividend?
TuHURA BIOSCIENCES, INC./NV didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is TuHURA BIOSCIENCES, INC./NV’s book value per share?
TuHURA BIOSCIENCES, INC./NV’s book value is $0.29 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of TuHURA BIOSCIENCES, INC./NV have?
Each share of TuHURA BIOSCIENCES, INC./NV has $0.02 of cash and investments and $0.06 of debt, as of June 30, 2026.
What is TuHURA BIOSCIENCES, INC./NV’s free cash flow per share?
−$0.53 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has TuHURA BIOSCIENCES, INC./NV bought back shares?
TuHURA BIOSCIENCES, INC./NV’s share count rose about 322998% from 2013 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.